Shifting the focus from open release of genetically modified mosquitoes, to controlled individualized treatment for infectious diseases

dc.contributor.authorde Souza, D.K.
dc.contributor.authorDadzie, S.
dc.contributor.authorOsei, J.H.N.
dc.contributor.authorBoakye, D.A.
dc.contributor.authorSuzuki, T.
dc.date.accessioned2019-01-22T10:21:54Z
dc.date.available2019-01-22T10:21:54Z
dc.date.issued2012-12
dc.description.abstractGenetically modified (GM) vectors offer an opportunity for the control of many infectious diseases including malaria and dengue. However, they face issues of ethical consent, public and social acceptance and environmental concerns. Thus, strategies are needed to address these concerns before GM mosquitoes could be openly released. One example, the use of GM mosquitoes as "Flying Vaccinators" that have been designed to produce vaccine candidates, may provide some solutions to the concerns raised against GM vectors.en_US
dc.identifier.otherVol. 20(4): pp 117
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/26969
dc.language.isoenen_US
dc.publisherAsia-Pacific Journal of Molecular Biology and Biotechnologyen_US
dc.subjectFlying vaccinatorsen_US
dc.subjectGenetically modified mosquitoes (GMM)en_US
dc.subjectInfectious diseasesen_US
dc.titleShifting the focus from open release of genetically modified mosquitoes, to controlled individualized treatment for infectious diseasesen_US
dc.typeOtheren_US

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: